WO2025133899 - TOPICAL COMPOSITION COMPRISING DUTASTERIDE AND LATANOPROST FOR ALOPECIA
National phase entry is expected:
Publication Number
WO/2025/133899
Publication Date
26.06.2025
International Application No.
PCT/IB2024/062753
International Filing Date
17.12.2024
Title **
[English]
TOPICAL COMPOSITION COMPRISING DUTASTERIDE AND LATANOPROST FOR ALOPECIA
[French]
COMPOSITION TOPIQUE COMPRENANT DU DUTASTÉRIDE ET DU LATANOPROST POUR L'ALOPÉCIE
Applicants **
GLENMARK SPECIALTY S.A.
Inventors
OTAVKAR, Roopali
ABRAHAM, Jaya
BANGAR, Ganesh
DHUPPAD, Ulhas
KULKARNI, Abhay
GANDHI, Maulik
UDUPA, Venkatesh
PAWAR, Pramod
CHOPADE, Atul
Priority Data
202321086744
19.12.2023
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2098 | |
| EPO | Filing, Examination, Granting | 9134 | |
| Japan | Filing, Examination, Granting | 2214 | |
| South Korea | Filing, Examination, Granting | 2197 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,383
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to the use of combination of 5α-reductase inhibitors and prostaglandin analogues for preventing hair loss and/or stimulating hair growth. The present invention also relates to topical composition containing 5α-reductase inhibitors and prostaglandin analogues for preventing hair loss and/or stimulating hair growth on the scalp. The present invention also relates to composition and methods for treating certain hair loss disorders such as androgenetic alopecia.[French]
La présente invention concerne l'utilisation d'une combinaison d'inhibiteurs de 5α-réductase et d'analogues de prostaglandine pour prévenir la chute des cheveux et/ou stimuler la pousse des cheveux. La présente invention concerne également une composition topique contenant des inhibiteurs de 5α-réductase et des analogues de prostaglandine pour prévenir la chute des cheveux et/ou stimuler la pousse des cheveux sur le cuir chevelu. La présente invention concerne également une composition et des méthodes de traitement de certains troubles liés à la perte de cheveux tels que l'alopécie androgénétique.